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Abstract An unusual form of painful congenital myotonia is
associated with a novel SCN4A mutation causing a valine to
methionine substitution in the domain 1/S6 segment of the
skeletal muscle sodium channel. We studied the functional
characteristics of this mutant allele using a recombinant channel
to gain understanding about the nature of the biophysical defect
responsible for this unique phenotype. When expressed heterol-
ogously in a cultured mammalian cell line (tsA201), the mutant
channel exhibits subtle defects in its gating properties similar, but
not identical, to other myotonia-producing sodium channel
mutations. The main abnormalities are the presence of a small
non-inactivating current that occurs during short test depolariza-
tions, a shift in the voltage-dependence of channel activation to
more negative potentials, and a slowing of the time course of
recovery from inactivation. Flecainide, a potent sodium channel
blocker previously reported to benefit patients affected by this
form of myotonia, effectively inhibits the abnormal sodium
current associated with expression of the mutant channel. Our
findings demonstrate the unique pattern of sodium channel
dysfunction associated with a D1/S6 myotonia-producing sodium
channel mutation, and provide a mechanism for the beneficial
effects of flecainide in this setting.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
A variety of inherited syndromes have been linked to mu-
tations in voltage-gated sodium channels [1^3]. Mutations in
the skeletal muscle sodium channel K-subunit gene (SCN4A,
17q) cause various forms of non-dystrophic myotonia and
periodic paralysis [4]. To date, there have been approximately
20 SCN4A mutations reported with the majority resulting in
amino acid substitutions within the third or fourth repeat
domains of the channel [5]. Interestingly, there has been a
conspicuous absence of mutations in the ¢rst repeat domain
(D1) fueling speculation that mutations in this region of a
voltage-gated sodium channel would either be inconsequential
or possibly lethal.
We recently reported the discovery of the ¢rst known so-
dium channel D1 mutation, a valine to methionine substitu-
tion in the D1/S6 segment (V445M), in an unusual form of
painful congenital myotonia [6]. The phenotype associated
with this mutation is su⁄ciently distinct from other inherited
disorders of muscle membrane excitability associated with
SCN4A mutations (paramyotonia congenita, hyperkalemic
periodic paralysis, and potassium aggravated myotonia) that
we postulated it might be associated with a unique pattern of
sodium channel dysfunction. We have now characterized this
mutation using heterologous expression of recombinant mu-
tant and wild-type (WT) skeletal muscle sodium channel K
subunits (hSkM1). Our ¢ndings established that the mutation
causes a defect in sodium channel gating that is compatible
with a myotonia-producing lesion. The pattern of dysfunction
is distinct from other muscle sodium channel mutations and
this observation supports the notion that D1 sodium channel
mutations may be associated with unusual phenotypes. We
also demonstrated that £ecainide e¡ectively suppressed the
abnormal channel behavior consistent with the drug’s ob-
served clinical e⁄cacy in treating the associated unusual
form of myotonia.
2. Materials and methods
2.1. Site-directed mutagenesis
Valine-445 was replaced by methionine in the hSkM1 cDNA [7]
using a cassette mutagenesis strategy. Two complementary oligonu-
cleotides were synthesized and annealed together to form a 70 base
pair product containing the mutation, as well as HinDIII and S¢I
compatible overhangs. The double-stranded cassette sequence was
also designed to eliminate a nearby S¢I recognition site by a silent
mutation for use as an allele-speci¢c marker. The double-stranded
mutant cassette was phosphorylated using T4 polynucleotide kinase
and subcloned into the HinDIII and S¢I sites of a modi¢ed hSkM1
cDNA (hSkM1-A) [8] in the mammalian expression plasmid
pRcCMV. Recombinants were analyzed by restriction digestion and
sequenced fully in the region containing the mutant cassette.
2.2. Expression of sodium channels in tsA201 cells
Transfection-quality plasmid DNA was prepared using the Qiagen
method. Cultured tsA201 cells were grown and transiently transfected
as previously described [9]. Transiently transfected cells were exam-
ined 48 h after transfection following mechanical dissociation from
the culture dish.
2.3. Electrophysiology
Sodium channel expression was examined using the whole cell con-
¢guration of the patch clamp technique, as previously described [9].
All measurements were made using the pCLAMP suite of programs
and analyzed as previously described [9]. The time course of sodium
current inactivation was quanti¢ed by ¢tting the falling phase of
each current tracing with exponential functions: V445M required a
two exponential function, y = A1Wexp(3t/d1)+A2Wexp(3t/d2)+C, where-
as hSkM1 data required a single exponential function, y = A1Wexp(3t/
d1)+C, where A is the amplitude of the current component, d is a time
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constant, and C represents the amount of non-inactivating current.
Recovery from inactivation was assessed by a standard two-pulse
protocol. Channels were inactivated by a 500 ms prepulse to +20
mV. The fraction of channels that had recovered following various
time intervals at 3120 mV was calculated by dividing the peak current
measured during a subsequent test pulse to 320 mV by the current
measured (at 320 mV) after clamping the cell for 10 s at 3120 mV. A
two-pulse protocol was used to assess the voltage-dependence of
steady-state inactivation using a 500 ms prepulse to di¡erent mem-
brane potentials. The fraction of channels not inactivated by the pre-
pulse was estimated from the peak inward current during a 20 ms test
potential to 320 mV. The voltage-dependence of channel activation
was assessed by measuring peak sodium current at di¡erent test po-
tentials. Peak sodium current values were divided by the electrochem-
ical driving force (EM3ENa) and normalized to the maximum value
measured at +20 mV.
2.4. Computer simulations of muscle action potentials
Sarcolemmal action potentials were simulated using a modi¢ed
Hodgkin^Huxley mathematical model as previously described [10].
Parameters were changed to simulate the behavior of a 1:1 mixture
of WT and mutant sodium channels as would exist in a heterozygous
muscle ¢ber. A slow component of inactivation was included in the
mutant simulations using a relative rate constant of 0.15. Also, to
simulate the slower time course of recovery from inactivation ob-
served with V445M, the rate constants for fast and slow components
of inactivation recovery were multiplied by 0.67 and 0.296, respec-
tively. Simulated action potentials were elicited by a 20 ms, 160 WA/
cm2 stimulus at 37‡C.
3. Results and discussion
3.1. Functional properties of V445M
We performed experiments to examine the general function-
al properties of V445M transiently expressed in tsA201 cells.
Fig. 1 illustrates representative whole cell current recordings
from cells transfected with either wild-type (WT) or mutant
(V445M) hSkM1 cDNA. Sodium currents were elicited by a
series of test depolarizations from a holding potential of 3120
mV. Expression of both WT and mutant channels was equally
robust and there was no signi¢cant di¡erence between the
recorded peak current amplitudes. There were no readily ap-
parent di¡erences in the time course of either activation or
inactivation of the whole cell current traces shown in Fig. 1A
and B, however, mutant channels exhibit a small (1^2% of
peak current) persistent current during the late phase of the
test depolarization. This late current component is illustrated
more clearly by the Fig. 1B inset showing superimposed, nor-
malized current recordings in response to a 320 mV test de-
polarization. Sodium currents recorded in cells transfected
with V445M do inactivate fully during longer (100 ms) test
depolarizations (data not shown). Current-voltage relation-
ships for WT and mutant channels are illustrated in Fig. 1C
and D. The midpoint of the descending limb of the current-
voltage relationship and the voltage producing peak current
amplitude appear shifted to more negative potentials in the
mutant (compared with WT) suggesting that there may be
changes in the voltage-dependence of channel gating (see be-
low).
The time course of inactivation was quanti¢ed by ¢tting the
data shown in Fig. 1A and B with exponential functions. The
time course of current decay in cells transfected with WT-
hSkM1 could be well ¢t with a single exponential function,
but the time course of inactivation in cells transfected with
V445M required a two exponential ¢t. Fig. 2 illustrates the
voltage-dependence of inactivation time constants for both
WT and mutant channels. The time constants for WT inacti-
vation are similar to the fast component of the mutant, but
V445M channels exhibit additional slow and late current com-
ponents. These data illustrate a defect in fast inactivation ex-
hibited by the mutant channel. The time course of recovery
from inactivation was also determined and is illustrated in
Fig. 2C. By contrast to many other myotonia-producing so-
dium channel mutations that accelerate the time course of
recovery from inactivation [11^13], the V445M allele appears
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Fig. 1. Current-voltage relationships for WT hSkM1 and V445M. A: Whole cell currents recorded from tsA201 cells expressing WT-hSkM1
elicited by a series of test potentials between 380 mV and +50 mV from a holding potential of 3120 mV. B: Currents recorded from tsA201
cells expressing WT-hSkM1 elicited with the same protocol as in panel A. Inset shows normalized current records obtained with a test depolari-
zation to 320 mV on an expanded scale to illustrate the non-inactivating current. C, D: Peak inward current plotted as a function of mem-
brane potential for hSkM1 (C) or V445M (D). Solid curves through data points in C and D were generated by the equation:
INa = gNaW[1+exp(Vm3V1=2)/k]31W[Vm3ENa]. The midpoint values (V1=2) for the descending limb of the two curves were 325 and 338 mV for
hSkM1 and V445M, respectively.
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to produce slowing of this process. It is di⁄cult to compare
the time course of recovery from inactivation for WT and
V445M quantitatively because of a di¡erence in the number
of exponential components required for ¢tting these curves.
Steady-state inactivation and conductance vs. voltage plots
are shown in Fig. 2D for both WT and mutant channels.
There is no signi¢cant di¡erence in steady-state inactivation
between the two channel alleles. However, the voltage-de-
pendence of activation is shifted signi¢cantly to more negative
potentials in the mutant (V445M: 336.2 þ 0.5 mV, n = 9 vs.
WT-hSkM1: 332.7 þ 0.8 mV, n = 13; P6 0.01). This shift in
the voltage-dependence of activation along with the defect in
fast inactivation are likely to be important factors responsible
for myotonia associated with this mutation.
3.2. Computer simulation of V445M action potentials
Our ¢ndings reveal subtle defects in V445M gating, similar,
but not identical, to other previously characterized myotonia-
associated SCN4A mutations [11^16]. To evaluate whether the
degree of dysfunction exhibited by V445M is su⁄cient to in-
duce sarcolemmal hyperexcitability, we simulated skeletal
muscle action potentials using a modi¢ed Hodgkin^Huxley
mathematical model [10]. The rate constants for channel gat-
ing characteristics used by the model were modi¢ed to ac-
count for the behavior of the mutant (see Section 2), and
simulations assumed heterozygosity for mutant and WT chan-
nels replicating the autosomal dominant transmission ob-
served in the associated disease phenotype [6]. Fig. 3 illus-
trates the results of this analysis showing that only a single
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Fig. 3. Computer simulations of muscle action potential behavior
for WT-hSkM1 or V445M expressing muscle ¢bers. Simulated mem-
brane responses to a 20 ms, 160 WA/cm2 stimulus at 37‡C for
muscle cells expressing WT-hSkM1 alone (WT) or a 1:1 ratio of
WT and V445M mutant channels. Model parameters were modi¢ed
as described in Section 2.
Fig. 2. Quantitative analyses of WT-hSkM1 and V445M gating. A: Relative amplitudes of the fast (a), slow (E), and late (O) inactivating cur-
rent components observed for V445M. B: Inactivation time constants for hSkM1 and V445M (symbols de¢ned in the inset legend). V445M
currents required a two exponential ¢t thus giving two time constants. C: Recovery from inactivation for WT-hSkM1 and V445M. The best ¢t-
ting exponential functions for WT-hSkM1 (three components) and V445M (two components) are shown as solid lines obtained from the aver-
aged data. Time constants are as follows (component amplitudes are in parentheses): WT-hSkM1: d1 = 0.8 ms (31%), d2 = 59.8 ms (46%),
d3 = 459 ms (23%); V445M: d1 = 77.4 ms (54.8%), d2 = 607.5 ms (45.2%). D: Comparison of steady-state inactivation (circles) and activation (tri-
angles) curves for WT-hSkM1 (¢lled symbols) and V445M (open symbols). The curves shown are normalized to the maximum sodium conduct-
ance in each experiment and ¢tted with Boltzmann functions. Values for half-maximal inactivation (V0:5) are as follows: WT-hSkM1,
377.3 þ 1.0 mV (n = 8); V445M, 378.1 þ 0.8 mV (n = 15) (NS). Values for half-maximal activation are as follows: WT-hSkM1, 332.7 þ 0.8 mV
(n = 13); V445M, 336.2 þ 0.5 mV (n = 9) (P6 0.01).
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action potential is generated in response to a 20 ms stimulus
in simulated WT muscle ¢bers. By contrast, modi¢cation of
the model to incorporate changes in inactivation kinetics as
observed with V445M results in myotonic-like repetitive ac-
tion potentials. These results strongly suggest that the bio-
physical defect observed for V445M is su⁄cient to cause my-
otonia.
3.3. E¡ect of £ecainide on WT and mutant sodium channels
The V445M mutation is associated with an unusual form of
myotonia that is relatively refractory to the anti-myotonic
compound mexiletine, but a¡ected individuals respond dra-
matically to the potent sodium channel blocker £ecainide
[6]. Therefore we tested the e¡ects of this compound on
both WT and V445M channels. Fig. 4 illustrates the e¡ect
of 10 WM £ecainide on currents elicited by a single test depol-
arization in cells transiently transfected with either WT-
hSkM1 or V445M. Peak current amplitudes are reduced by
£ecainide in both WT-hSkM1 and V445M expressing cells,
but the proportional decrease in the current is not signi¢cantly
di¡erent between the two channel alleles. In addition to using
the reduction in peak current amplitude as a measure of drug
sensitivity, we also evaluated the proportional reduction in
total current by comparing the area under the current traces
[17] before and after application of £ecainide. We observed
that drug block of total current exhibited by V445M is sig-
ni¢cantly greater than block of peak current (Fig. 4C). The
likely explanation for this di¡erence is that £ecainide more
e¡ectively suppresses the late current component in the mu-
tant as compared to its e¡ect on peak current (see ‘Area-late’
bar in Fig. 4C). This is illustrated further in Fig. 4D showing
an expanded view of superimposed current records for the
mutant before and after application of 10 WM £ecainide.
Although the drug concentration used in this in vitro study
is higher than the therapeutic concentration, these results sug-
gest that the bene¢cial e¡ect of £ecainide in patients with
V445M is likely due to selective suppression of the abnormal
sodium current component. Selective drug suppression of
non-inactivating behavior of mutant cardiac sodium channels
that occurs in the congenital long QT syndrome has been
similarly observed [18].
4. Conclusions
The novel SCN4A mutation V445M is associated with an
unusual form of mexiletine refractory, painful congenital my-
otonia and is caused by subtle defects in the inactivation
properties of the mutant sodium channel. The observed func-
tional disturbances including a shift in the voltage-dependence
of activation to more negative potentials and the occurrence
of a small non-inactivating current component, help to ex-
plain the pathogenesis of myotonia associated with the
V445M mutation. Finally, the selective suppression by £eca-
inide of the inactivation defect associated with this sodium
channel allele suggests that additional studies to determine
the clinical utility of this compound in treating other forms
of myotonia caused by SCN4A mutations are warranted.
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Fig. 4. Flecainide block of WT-hSkM1 and V445M. A: Sodium
currents recorded from a cell expressing WT-hSkM1 during a single
100 ms test depolarization to 320 mV from a holding potential of
3120 mV before (control) and after application of 10 WM £ecainide.
B: E¡ect of £ecainide on currents recorded from a cell expressing
V445M. C: Summarized data illustrating e¡ects of £ecainide on
peak sodium current (‘Peak’) and the total integrated current
(‘Area’) for both WT (n = 7) and mutant sodium channels (n = 4).
The e¡ect of £ecainide on V445M current measured between 2.5
and 20 ms after the test depolarization (‘Area-late’) is also shown.
D: Expanded scale of V445M non-inactivating currents before (con-
trol) and after application of 10 WM £ecainide.
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